Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
For small and micro-businesses, regulatory compliance isn’t just a requirement—it’s a gateway to market credibility. Yet, without the right support, this can be an intimidatingly complex pathway. Advena’s deep regulatory expertise opens doors, transforming compliance into a strategic asset that accelerates clients’ journeys to market. “Our goal is to empower clients by simplifying the regulatory process, driving innovation rather than becoming an obstacle,” explains Kirsty Ostle, Managing Director. Advena’s robust suite of services includes navigating complex UK and EU regulatory and quality frameworks, to fulfilling essential roles such as the UK Responsible Person, a role required by the UK Medical Device Regulations for non-UK manufacturers and Person Responsible for Regulatory Compliance (PRRC) required by the EU Medical Device and IVD Regulations. This way, Advena becomes a committed partner at every stage of the compliance journey. Not only does it ensure compliance, but it also strengthens clients’ operations from the ground up. Through audits aligned with ISO 13485 and ISO 9001, Advena introduces best practices that enhance operational resilience. Its seasoned auditors conduct thorough reviews, assessing both in-house and supplier processes, evaluating quality management systems and delivering actionable recommendations to elevate client efficiency and reliability. Education is woven into everything Advena does. Beyond traditional consulting, it empowers clients through tailored training, auditing and supplier assessments that build both confidence and knowledge. Bespoke training sessions—available virtually or onsite—equip teams with practical skills, ensuring they are well-prepared to meet regulatory demands independently and sustainably. For businesses looking to establish themselves in complex markets, Advena is a versatile resource, turning compliance into a true competitive edge.
Biochem Consulting, a renowned consultancy firm, has solidified its position as a market leader in the field of healthcare advisory services, pioneering groundbreaking solutions and delivering unparalleled expertise to clients worldwide. With a focus on pharmaceuticals, medical devices, food supplements, cosmetics, and biocides industries, it offers unparalleled technical expertise and assistance to businesses seeking to excel in these domains. At the helm of Biochem Consulting is Ermando Maisto, the visionary CEO who articulates the company's mission succinctly: "Our objective at Biochem Consulting is to provide bespoke solutions that focus on the cost-to-benefit ratio while delivering prompt services to our clients." What sets Biochem Consulting apart is its multidisciplinary team of experts, comprising seasoned pharmacists, chemists, biologists, and engineers, who collectively possess two decades of industry experience. Drawing upon their extensive knowledge and diverse skill sets, this talented group spearheads the development of solutions for the challenges faced by the clients. Biochem Consulting profoundly understands the complex technical and procedural aspects associated with regulatory bodies. This expertise allows the company to comprehensively address the unique needs of its clients, offering solutions that meet regulatory requirements while promoting business growth. Biochem Consulting plays a critical role for manufacturers and producers in the medical device regulations landscape. By crafting a regulatory strategy that aligns with the specific needs of customers in the medical devices sector, the company has successfully aided businesses in adapting to the new European Union (EU) Regulation 2017/745. Through the provision of essential technical documentation and guidance in identifying optimal safety tests, Biochem Consulting has ensured seamless compliance for its clients. The company extends its expertise to encompass various critical aspects of medical device manufacturing. From conducting clinical evaluations in accordance with MDR (EU) 2017/745 to performing risk analysis in compliance with ISO 14971, Biochem Consulting offers comprehensive support.
Medical Device Design and Development
Dan Dror Siman-Tov, Senior Director of R&D , Meridian Bioscience
Medical Device Manufacturing
Daniel Schaudel, Head of Clinical Systems/Research & Development, MED-EL
Medical Device Manufacturing
Patty Ryan, Sr. Director, Chief Information Security Officer, QuidelOrtho
Medical Device Consulting
Alphons Vincent, Medical Director at Medtronic
Medical Device Manufacturing
Eric Huang, Engineering Manager, Alcon, United States of America
The medical device industry thrives at the intersection of cutting-edge innovation and life-changing impact. From wearable health monitors to robotic surgical systems, every breakthrough promises to redefine patient care. Yet, behind the scenes, navigating the intricate web of regulatory compliance is as critical as the innovation itself.
Behind every pacemaker, surgical robot or AI diagnostic tool is a rigorous process that ensures it’s safe, effective and ready to transform lives. Medical device regulation stands as the backbone of innovation—where cutting-edge technology meets oversight. And with advances like AI and digital tools, the regulatory world is becoming faster, smarter and more collaborative than ever.
Driving Innovation through Compliance Excellence
The global medical devices market was valued at USD 562.6 billion in 2024 and is expected to grow at a CAGR of 6.2 percent during the forecast period of 2025-2034 and reach a market value of USD 965.2 billion by 2034. From navigating the complexities of FDA submissions in the U.S. to achieving CE markings in Europe, regulatory pathways are pivotal in ensuring that innovative medical technologies meet the highest safety and efficacy standards. This environment underscores the indispensable role of regulatory consulting firms, which provide the expertise needed to navigate these challenges efficiently.
This edition of MedTech Outlook spotlights Advena as the Medical Devices Regulatory Consulting Company of the Year in UK 2025. Advena specialises in providing regulatory consulting services for small—to medium-sized businesses in the medical technology sector. The company also focuses on tailored, cost-effective solutions that help clients navigate complex regulatory environments, ensuring compliance and successful market entry for their innovative medical devices.
The publication also features thought leadership articles from key opinion leaders. One of them, Eric Huang, Engineering Manager, Alcon, emphasizes the importance of challenging established rules in medical device manufacturing and highlights the potential to improve device quality, production yield and innovation through collaboration and courage. The issue also features insights from Patty Ryan, Sr. Director, Chief Information Security Officer of QuidelOrtho, who underscores the transformative role of AI in information security and its potential for threat detection, secure development and data protection.
We also spotlight pioneering companies that have embraced regulatory consulting to achieve remarkable milestones. From wearable health monitors gaining fast-track approval to AI-powered diagnostic tools navigating stringent global standards, these success stories highlight the transformative impact of expert regulatory guidance in advancing healthcare innovation.
We hope this edition inspires you to explore the possibilities in this everevolving device regulatory consulting domain. Let us know your thoughts!
